Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Deutsche Lufthansa AG    LHA   DE0008232125

DEUTSCHE LUFTHANSA AG

(LHA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Positive about flying? Airlines look to COVID tests that give results in minutes

09/23/2020 | 02:13am EST
FILE PHOTO: A woman wearing a face mask waits with other passengers at the check-in area for an Alitalia, after further cases of coronavirus were confirmed in New York, at JFK International Airport in New York

European airlines are pinning hopes on pre-flight COVID-19 tests that deliver results as fast as pregnancy tests to help restore passengers' confidence in taking to the skies in confined spaces with shared air.

Germany's Lufthansa, at the mercy of government bailouts for survival, is in talks with Swiss drugmaker Roche over deploying so-called antigen tests, according to two people familiar with the discussions, as the airline aims to make them available next month.

Italian operator Alitalia, meanwhile, told Reuters that from Wednesday it would add two flights from Milan to Rome, to the two it is already offering from Rome to Milan, exclusively for passengers with negative tests.

The tests are administered by health authorities at the airports and included in ticket prices. If they prove popular and safe, these antigen-tested flights will be expanded to more domestic, and later international, routes, the airline said.

Unlike laboratory-based molecular tests that have been the staple of health authorities in the pandemic, antigen tests do not require machines to process. Much like pregnancy tests, they can produce results in about 15 minutes.

However the tests require an uncomfortable nasal swab and are not as accurate as the molecular, or PCR, tests. They generally produce more "false negatives" which could mean sick people could slip through the cracks and onto planes.

An increasing number are hitting the market, from companies such as Abbott Laboratories, Becton Dickinson & Co and Quidel Corp and Roche, which is rebranding antigen tests from South Korea's privately held SD Biosensor.

Airlines are pressing governments to embrace alternatives to blanket travel restrictions amid a resurgence of COVID-19 cases in Europe.

Rapid antigen tests that can be administered by non-medical staff are expected to become available in coming weeks for as little as $7 each, the head of industry body the International Air Transport Association said on Tuesday.

NEGATIVE-ONLY FLIGHTS

Despite the drawbacks of such antigen tests, carriers hope they could tip the balance in convincing people to fly.

"It is to give ... confidence, at a specific point in time, that the result is positive or negative," said Christian Paulus, a Roche research and development manager.

"The PCR remains the gold standard. Therefore if there are any questions open, or if the clinical appearance of the person who had a negative test, if the person has symptoms like a fever, then you would for sure do confirmatory testing."

Alitalia launched its "COVID Tested Flights" programme from Rome to Milan last week, and will expand it from Wednesday. Only passengers with negative COVID-19 results can board.

"So far no positive passengers have been found," said an Alitalia spokesman, adding that many chose to take the airline's antigen tests the night before the flight. Travellers can access airport-testing facilities via a preferred lane with their tickets.

The airline plans to analyse findings around the middle of October, but already expects antigen-tested flights will be expanded to domestic and later international routes. "First, we have to see how this experiment goes," the spokesman said.

The pre-flight antigen tests follow a scheme in Italy where such tests were used defensively.

SD Biosensor said its tests had been deployed at Italian airports for incoming tourists, to avoid a renewed COVID-19 wave imported from infection hotspots.

'BETTER THAN QUARANTINE'

Lufthansa Chief Executive Carsten Spohr last week told employees during a townhall meeting that the airline was in talks with Roche. The drugmaker started selling the rapid tests this week, and said SD Biosensor could initially supply it with about 40 million tests per month.

The Lufthansa tests could initially go to cabin crews, a spokeswoman said, though Bjoern Becker, a senior director of product management, ground & digital services for the Lufthansa Group, said the tests could also be made available to first-class and business-class passengers.

"We think the tests would be a better option than putting somebody into quarantine," the airline spokeswoman said.

Beyond airlines, Germany is eyeing broader antigen test use from October, including in nursing homes where older patients have been hardest hit by the deadly virus.

Regulators still worry about test accuracy, which typically detect the virus 80% to 90% of the time, below the 95% rate of lab tests.

Still, some officials don't want the perfect to be the enemy of the pretty good as they pursue some semblance of economic normality.

"They're good enough," German health minister Jens Spahn said, pledging antigen tests in "significant quantities". The state of Bavaria has already ordered 10 million.

By John Miller and Emilio Parodi


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES -1.52% 107.61 Delayed Quote.25.80%
BECTON, DICKINSON AND COMPANY 0.35% 229.29 Delayed Quote.-15.99%
DEUTSCHE LUFTHANSA AG 7.11% 10.45 Delayed Quote.-40.55%
QUIDEL CORPORATION -0.95% 174.44 Delayed Quote.134.72%
ROCHE HOLDING AG -0.53% 300.55 Delayed Quote.-3.77%
All news about DEUTSCHE LUFTHANSA AG
11:44aDEUTSCHE LUFTHANSA : Lufthansa to raise $1.2 billion from junk bond markets
RE
10:22aGermany's DAX index gets shake-up in wake of Wirecard scandal
RE
11/23Australia opens up more borders in domestic travel boost, eyes vaccine
RE
11/20DEUTSCHE LUFTHANSA : Management change at three Lufthansa Group airlines
AQ
11/19DEUTSCHE LUFTHANSA : Dieter Vranckx appointed as SWISS's new CEO
AQ
11/19DEUTSCHE LUFTHANSA : Announcement of the declaration on the issue of the convert..
PU
11/18DEUTSCHE LUFTHANSA : Management change at three Lufthansa Group airlines
PU
11/18LUFTHANSA AG : Independant Research gives a Sell rating
MD
11/18LUFTHANSA AG : Bernstein remains Neutral
MD
11/18LUFTHANSA AG : Gets a Neutral rating from Bernstein
MD
More news
Financials
Sales 2020 14 074 M 16 718 M 16 718 M
Net income 2020 -5 831 M -6 927 M -6 927 M
Net Debt 2020 11 918 M 14 157 M 14 157 M
P/E ratio 2020 -0,93x
Yield 2020 0,02%
Capitalization 6 246 M 7 422 M 7 420 M
EV / Sales 2020 1,29x
EV / Sales 2021 0,80x
Nbr of Employees 124 534
Free-Float 81,5%
Chart DEUTSCHE LUFTHANSA AG
Duration : Period :
Deutsche Lufthansa AG Technical Analysis Chart | LHA | DE0008232125 | MarketScreener
Technical analysis trends DEUTSCHE LUFTHANSA AG
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 22
Average target price 6,20 €
Last Close Price 10,45 €
Spread / Highest target 34,9%
Spread / Average Target -40,6%
Spread / Lowest Target -80,9%
EPS Revisions
Managers
NameTitle
Carsten Spohr Chairman-Executive Board & CEO
Karl-Ludwig Kley Chairman-Supervisory Board
Roland Schütze Chief Information Officer
Christine Behle Deputy Chairman-Supervisory Board
Christina Weber Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
DEUTSCHE LUFTHANSA AG-40.55%6 889
DELTA AIR LINES, INC.-33.67%24 637
RYANAIR HOLDINGS PLC6.08%20 631
AIR CHINA LIMITED-19.85%15 528
CHINA SOUTHERN AIRLINES COMPANY LIMITED-6.30%12 993
UNITED CONTINENTAL HOLDINGS, INC.-53.54%11 910